Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3BCHECHRM1CHRM2CHRM3CHRM4CHRNA3CHRNA4CHRNB2CHRNB4ESR1ESR2GABRA1GABRB1GABRG2GBA1GHSRHRH1HTR1DHTR2AMAOBOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8UGCGrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL30689288 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL848 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Tartaric Acid SCHEMBL29430365 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL1062721 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL116846 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL29382062 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL31427568 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Tartaric Acid SCHEMBL5762 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL1431070 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL3065246 | 1.00 | TSHR (1.00) | TSHRTP53CYP2C9PDE4ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13580 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747257-A1 | SOLID STATE FORMS OF BUNTANETAP AND PROCESS FOR PREPARATION THEREOF | Assia Chemical Industries Ltd. (IL) | 2026-05-27 | — | — | EP | claimed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-120736974-B | Method for preparing calcium maleate, calcium cis-epoxy succinate or tartaric acid | Ningbo Jinzhan Biotechnology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| US-12630520-B2 | Left-handed bicyclic morpholine and salt thereof, preparation method therefor, pharmaceutical composition, and use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2026-05-19 | — | — | US | claimed |
| WO-2026098459-A1 | CRYSTALLINE FORM OF SUBSTITUTED 2-(PYRROLIDIN-3-YL) ACETATE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海翊石医药科技有限公司 | 2026-05-15 | — | — | WO | claimed |
| WO-2026098867-A1 | OXIDATIVE HAIR BRIGHTENING BY MEANS OF PERSULFATE, DICARBOXYLIC ACID, AND CITRULLINE | HENKEL AG & CO. KGAA (DE) | 2026-05-15 | — | — | WO | claimed |
| CN-117384030-B | Production method of bio-based succinic acid | 中国石油天然气股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260125390-A1 | SOLID FORMS OF MACROCYCLIC COMPOUNDS, SALTS AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE SAME | KURA ONCOLOGY INC (US) | 2026-05-07 | — | — | US | claimed |
| WO-2026086809-A1 | PROCESS FOR PREPARING 3- [ (3AS, 6AR) -5- {5-CHLORO-2- [ (1-METHYL-1H-PYRAZOL-4-YL) AMINO] PYRIMIDIN-4-YL} -3A-METHYL-OCTAHYDROPYRROLO [3, 4-C] PYRROLE-2-YL] -3-OXOPROPIONITRILE | BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) | 2026-04-30 | — | — | WO | claimed |
| EP-4731205-A2 | SOLID FORMS OF POSIPHEN D-TARTRATE | Annovis Bio, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| EP-0029811-B1 | SHEATHED SURGICAL SUTURE FILAMENT AND METHOD FOR ITS PREPARATION | ASSUT SA (CH) | 1984-05-30 | — | — | EP | claimed |
| US-4353918-A | ANTIINFLAMMATORY, ANTIRHEUMATIC | CIBA-GEIGY CORPORATION (US) | 1982-10-12 | — | — | US | claimed |
| US-4317681-A | Modifiers for ion-leachable cement compositions | JOHNSON & JOHNSON (US) | 1982-03-02 | — | — | US | claimed |
| EP-0029811-A1 | Sheathed surgical suture filament and method for its preparation | ASSUT SA (CH) | 1981-06-03 | — | — | EP | claimed |
| WO-1981001368-A1 | SHEATHED SURGICAL SUTURE FILAMENT AND METHOD FOR ITS PREPARATION | BATTELLE MEMORIAL INSTITUTE (CH) | 1981-05-28 | — | — | WO | claimed |
| US-4150241-A | EPOXIDATION OF ALKALI MALEATE, TUNGSTATE CATALYST, HYDROLYSIS | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1979-04-17 | — | — | US | claimed |
| US-4124406-A | MIXTURE OF MESOTARTARIC ACID AND L-TARTARIC ACID OR D, L-TARTARIC ACID OR MIXTURE OF L-TARTARIC ACID AND D, L-TARTARIC ACID | DEUTSCHE GOLD UND-SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1978-11-07 | — | — | US | claimed |
| US-4101380-A | USING POLYOXYETHYLENE GLYCOL DERIVATIVES AND ACTIBATED CARBOXYLIC ESTERS | RESEARCH PRODUCTS REHOVOT LTD. (IL) | 1978-07-18 | — | — | US | claimed |
| US-4048225-A | MALEATE, HYDROGEN PEROXIDE, CATALYST | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-09-13 | — | — | US | claimed |
| US-3953504-A | Racemization of optically active tartaric acid | NIPPON PEROXIDE CO., LTD. (JA) | 1976-04-27 | — | — | US | claimed |